Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,108.40
(
-0.41%
)
US TECH 100
26,164.40
(
-0.15%
)
Dow Jones
49,310.32
(
-0.36%
)
Brent Oil
101.20
(
4.63%
)
Bitcoin
78,194.40
(
-0.06%
)
News Focus
News Focus
Post# of 257441
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biotech_researcher

Send PM Follow Ignore
Followers 85
Posts 12832
Boards Moderated 0
Alias Born 07/25/2008

biotech_researcher

Re: iandy post# 164123

Tuesday, 07/16/2013 6:15:15 PM

Tuesday, July 16, 2013 6:15:15 PM

Post# of 257441
IAndy, since many KOL's in EU and USA are moving to using second generation CML drugs first line, shouldn't you consider Pona as a "second" line treatment as well, instead of your message calling Ariad a third line drug? I don't think it is..
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today